These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 30496766)
41. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2. Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397 [TBL] [Abstract][Full Text] [Related]
42. Requirements of LEFTY and Nodal overexpression for tumor cell survival under hypoxia in glioblastoma. Matsumoto T; Chino H; Akiya M; Hashimura M; Yokoi A; Tochimoto M; Nakagawa M; Jiang Z; Saegusa M Mol Carcinog; 2020 Dec; 59(12):1409-1419. PubMed ID: 33111989 [TBL] [Abstract][Full Text] [Related]
43. A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma. Cheng WY; Kandel JJ; Yamashiro DJ; Canoll P; Anastassiou D PLoS One; 2012; 7(4):e34705. PubMed ID: 22493711 [TBL] [Abstract][Full Text] [Related]
44. Promising Prognosis Marker Candidates on the Status of Epithelial-Mesenchymal Transition and Glioma Stem Cells in Glioblastoma. Takashima Y; Kawaguchi A; Yamanaka R Cells; 2019 Oct; 8(11):. PubMed ID: 31653034 [TBL] [Abstract][Full Text] [Related]
45. Long non-coding RNA HOTTIP promotes hypoxia-induced epithelial-mesenchymal transition of malignant glioma by regulating the miR-101/ZEB1 axis. Zhang S; Wang W; Liu G; Xie S; Li Q; Li Y; Lin Z Biomed Pharmacother; 2017 Nov; 95():711-720. PubMed ID: 28886531 [TBL] [Abstract][Full Text] [Related]
46. GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis. Ku MC; Wolf SA; Respondek D; Matyash V; Pohlmann A; Waiczies S; Waiczies H; Niendorf T; Synowitz M; Glass R; Kettenmann H Acta Neuropathol; 2013 Apr; 125(4):609-20. PubMed ID: 23344256 [TBL] [Abstract][Full Text] [Related]
47. Low LINC00599 expression is a poor prognostic factor in glioma. Fu Q; Li S; Zhou Q; Yalikun K; Yisireyili D; Xia M Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30867254 [TBL] [Abstract][Full Text] [Related]
48. Reactive Astrocytes in Glioblastoma Multiforme. Guan X; Hasan MN; Maniar S; Jia W; Sun D Mol Neurobiol; 2018 Aug; 55(8):6927-6938. PubMed ID: 29363044 [TBL] [Abstract][Full Text] [Related]
49. Overexpression of vascular endothelial growth factor isoforms drives oxygenation and growth but not progression to glioblastoma multiforme in a human model of gliomagenesis. Sonoda Y; Kanamori M; Deen DF; Cheng SY; Berger MS; Pieper RO Cancer Res; 2003 Apr; 63(8):1962-8. PubMed ID: 12702589 [TBL] [Abstract][Full Text] [Related]
50. HDAC1 mediates epithelial-mesenchymal transition and promotes cancer cell invasion in glioblastoma. Cheng Z; Li S; Yuan J; Li Y; Cheng S; Huang S; Dong J Pathol Res Pract; 2023 Jun; 246():154481. PubMed ID: 37121053 [TBL] [Abstract][Full Text] [Related]
51. A Systems-Based Map of Human Brain Cell-Type Enriched Genes and Malignancy-Associated Endothelial Changes. Dusart P; Hallström BM; Renné T; Odeberg J; Uhlén M; Butler LM Cell Rep; 2019 Nov; 29(6):1690-1706.e4. PubMed ID: 31693905 [TBL] [Abstract][Full Text] [Related]
52. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT). Li J; Li Q; Lin L; Wang R; Chen L; Du W; Jiang C; Li R BMC Neurol; 2018 Aug; 18(1):133. PubMed ID: 30170559 [TBL] [Abstract][Full Text] [Related]
53. Integrins in glioblastoma: Still an attractive target? Paolillo M; Serra M; Schinelli S Pharmacol Res; 2016 Nov; 113(Pt A):55-61. PubMed ID: 27498157 [TBL] [Abstract][Full Text] [Related]
54. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties. Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554 [TBL] [Abstract][Full Text] [Related]
55. DRR1 promotes glioblastoma cell invasion and epithelial-mesenchymal transition via regulating AKT activation. Ma YS; Wu ZJ; Bai RZ; Dong H; Xie BX; Wu XH; Hang XS; Liu AN; Jiang XH; Wang GR; Jiang JJ; Xu WH; Chen XP; Tan GH; Fu D; Liu JB; Liu Q Cancer Lett; 2018 Jun; 423():86-94. PubMed ID: 29548818 [TBL] [Abstract][Full Text] [Related]
56. Dual-specificity phosphatase (DUSP6) in human glioblastoma: epithelial-to-mesenchymal transition (EMT) involvement. Zuchegna C; Di Zazzo E; Moncharmont B; Messina S BMC Res Notes; 2020 Aug; 13(1):374. PubMed ID: 32771050 [TBL] [Abstract][Full Text] [Related]
57. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis. Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037 [TBL] [Abstract][Full Text] [Related]
58. CCR7 Mediates TGF-β1-Induced Human Malignant Glioma Invasion, Migration, and Epithelial-Mesenchymal Transition by Activating MMP2/9 Through the Nuclear Factor KappaB Signaling Pathway. Zheng Y; Miu Y; Yang X; Yang X; Zhu M DNA Cell Biol; 2017 Oct; 36(10):853-861. PubMed ID: 28817313 [TBL] [Abstract][Full Text] [Related]
59. Bone marrow mesenchymal stem cells suppress growth and promote the apoptosis of glioma U251 cells through downregulation of the PI3K/AKT signaling pathway. Lu L; Chen G; Yang J; Ma Z; Yang Y; Hu Y; Lu Y; Cao Z; Wang Y; Wang X Biomed Pharmacother; 2019 Apr; 112():108625. PubMed ID: 30784920 [TBL] [Abstract][Full Text] [Related]
60. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma. Zhang H; Zhou Y; Cui B; Liu Z; Shen H Biomed Pharmacother; 2020 Jun; 126():110086. PubMed ID: 32172060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]